CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition
Folia Histochem Cytobiol. · 27.03.2026
DOI: 10.5603/fhc.111186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Histochem Cytobiol., online erschienen am 27.03.2026. Verfasst von Baoling Xing und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Affiliated Zhoupu Hospital of Shanghai University of Medicine and Health Sciences, Shanghai, China. 793506861@qq.com. Hauptthemen laut MEDLINE: MutL Protein Homolog 1, Endometrial Neoplasms, Wnt Signaling Pathway, Genomic Instability.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Affiliated Zhoupu Hospital of Shanghai University of Medicine and Health Sciences, Shanghai, China. 793506861@qq.com.
- Department of Pathology, Affiliated Zhoupu Hospital of Shanghai University of Medicine and Health Sciences, Shanghai, China.
Zitieren
APA
Xing, B., Zhang, X., Shen, L., & Zhang, X. (2026). CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition. Folia Histochem Cytobiol.. https://doi.org/10.5603/fhc.111186
Vancouver
Xing B, Zhang X, Shen L, Zhang X. CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition. Folia Histochem Cytobiol.. 2026. doi:10.5603/fhc.111186
BibTeX
@article{Xing2026,
author = {Xing, Baoling and Zhang, Xiaoying and Shen, Li and Zhang, Xinpeng},
title = {CRISPR-mediated MLH1 disruption suppresses endometrial cancer growth via genomic instability induction and Wnt/β-catenin pathway inhibition},
journal = {Folia Histochem Cytobiol.},
year = {2026},
doi = {10.5603/fhc.111186}
}
EUVIMED